Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.68 -2.32%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Lineage Cell Therapeutics Financial Ratios 2011-2025 | LCTX

Annual Financial Ratios Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-40.1 -38.2 -8.0 -16.1 -13.3 -3.9 -17.0 8.8 -4.1 -7.4 -4.8 -10.4 -16.9

P/S

91.8 126.8 198.6 181.5 44.3 36.1 98.0 49.6 27.4 51.7 47.1 56.8 64.1

EPS

-0.0 -0.0 -0.2 -0.1 -0.1 -0.4 -0.2 0.3 -0.6 -0.6 -0.8 -0.4 -0.3

EV (Enterprise Value)

195 M 283 M 260 M 312 M 160 M 166 M 311 M 284 M 169 M 254 M 219 M 224 M 261 M

EBITDA per Share

-0.03 -0.04 -0.17 -0.162 -0.246 -0.297 -0.326 -0.557 -0.746 -0.636 -0.638 -0.45 -0.344

EV/EBITDA

-0.6 -12.3 -4.1 -4.2 -8.1 -5.1 -2.5 -5.7 -5.9 -9.8 -15.7

PEG

1.36 1.45 0.41 -0.21 0.17 -0.04 0.11 -0.05 -0.56 0.23 -0.06 -0.4 -0.68

P/B

3.1 3.4 2.6 3.5 1.4 2.0 2.1 2.3 2.5 4.3 4.9 9.2 6.7

P/CF

-6.7 229.3 -9.8 -16.7 -4.8 -5.3 -10.6 -6.6 -3.9 -6.9 -6.6 -11.1 -19.2

ROE %

-7.53 -8.66 -31.44 -21.71 -10.53 -49.86 -12.16 25.72 -61.47 -58.05 -103.83 -88.19 -39.84

ROA %

-4.73 -5.14 -16.61 -19.13 -9.33 -45.24 -11.53 23.55 -49.64 -48.61 -76.01 -72.02 -36.04

ROCE %

-10.03 -9.05 -30.62 -26.40 -32.67 -43.22 -24.44 -44.10 -80.06 -74.78 -75.88 -98.59 -43.78

Current Ratio

2.6 2.4 2.1 5.7 8.9 5.3 6.2 2.9 3.8 4.5 1.1 1.6 7.9

DSO

91.1 4854.3 7912.5 0.8 2485.9 272.1 321.5 71.3 85.3 98.8 - - -

DIO

- - - - - - - - 0.3 116.0 82.3 46.5 -

DPO

1208.4 1488.1 787.6 2475.4 2150.1 2851.1 2037.9 1624.1 922.6 1001.5 1790.3 981.8 -

Operating Cycle

91.1 4854.3 7912.5 0.8 2485.9 272.1 321.5 71.3 85.7 214.8 82.3 46.5 -

Cash Conversion Cycle

-1117.3 3366.2 7124.9 -2474.6 335.8 -2579.0 -1716.4 -1552.8 -836.9 -786.6 -1708.0 -935.3 -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202320232022202220212021202020202019201920182018201720172016201620152015201420142013201320122012201120118000 8000 6000 6000 4000 4000 2000 2000 0 0 -2000 -2000
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Lineage Cell Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.02 -0.03 -0.04 - -0.04 -0.03 -0.03 - -0.04 -0.04 -0.04 -0.17 -0.05 -0.03 -0.01 0.01 -0.05 -0.04 -0.06 -0.03 -0.11 -0.2 0.3 -0.36 0.53 -0.03 -0.5 -0.58 0.12 -0.11 0.46 -0.05 0.3 0.26 -0.19 -0.16 -0.18 -0.12 -0.13 -0.14 -0.12 -0.16 -0.14 -0.35 -0.16 -0.14 -0.15 -0.12 -0.1 -0.11 -0.1 -0.1 -0.08 -0.09 -0.07

EBITDA per Share

-0.02 -0.03 -0.04 - -0.04 -0.03 -0.04 - 0.82 0.84 -0.04 -0.17 -0.04 -0.04 -43.3 -0.04 -0.04 -41.3 -0.05 -0.05 -0.05 -0.07 -0.09 -0.08 -0.08 -0.07 -0.09 -0.08 -0.08 -0.08 -104 -0.11 -83.3 -146 -258 -0.24 -206 -166 -0.17 -0.18 -0.17 -0.2 -0.19 -0.52 -0.18 -0.15 -0.16 -0.14 -0.11 -0.12 -0.12 -0.11 -0.08 -0.1 -0.08

ROE %

-32.72 -38.80 -37.71 -24.34 -32.16 -29.32 -30.28 -24.45 -55.88 -54.60 -50.18 -43.10 -9.55 -11.08 -13.98 -21.46 -27.54 -34.09 -53.90 -10.37 -55.13 30.59 52.68 -49.84 -45.33 -107.63 -110.31 -12.28 27.75 45.40 73.38 28.57 -19.56 -96.69 -153.54 -176.84 -153.51 -125.51 -115.59 -100.00 -203.52 -241.67 -266.56 -296.50 -226.98 -217.88 -223.81 -223.54 -178.49 -139.81 -97.81 -57.65 -13.05 -14.93 -11.74

ROA %

-21.47 -25.03 -24.11 -15.24 -19.87 -17.80 -18.09 -14.51 -31.12 -32.46 -31.04 -27.26 -8.77 -10.00 -12.48 -19.13 -24.58 -30.55 -48.44 -9.33 -49.98 28.81 48.60 -45.24 -42.54 -99.91 -102.49 -11.53 26.52 40.14 64.08 23.63 12.83 -23.45 -50.90 -49.64 -49.48 -46.13 -48.60 -48.67 -68.53 -73.09 -73.46 -76.02 -62.34 -63.41 -68.68 -72.02 -62.94 -54.43 -45.42 -36.04 -8.16 -9.33 -7.34

ROCE %

- - - - -6.77 -13.54 -18.74 -19.47 -50.09 -49.04 -49.58 -48.12 -23.61 -24.88 -25.81 -27.49 -27.46 -27.93 -30.85 -34.42 -39.29 -42.87 -43.03 -44.72 -39.65 -34.46 -29.98 -23.92 -27.58 -29.83 -36.78 -47.02 -86.78 -131.34 -160.83 -187.39 -172.75 -149.33 -139.10 -122.21 -213.22 -227.74 -231.09 -240.20 -180.83 -192.91 -215.19 -234.79 -186.73 -145.05 -104.64 -62.56 -14.17 -16.68 -13.48

Current Ratio

3.0 2.9 2.9 2.6 2.7 2.8 2.6 2.4 2.5 2.5 2.4 2.1 11.3 12.1 11.3 8.4 8.4 8.4 8.4 8.8 8.8 8.8 8.8 10.8 10.8 10.8 10.8 19.3 19.3 19.3 19.3 11.8 11.8 11.8 11.8 5.2 5.2 5.2 - - - - - - - - - - - - - - - - -

DSO

7.7 10.1 26.0 - 30.7 8.2 9.0 - 14.7 8.6 444.0 2061.0 42.6 - 28.2 62.2 19.3 - 3.9 1.6 - - 2.5 3.1 - - 9.1 6.7 - - 40.2 14.2 - - 16.6 49.5 23.9 26.1 41.7 30.1 42.1 45.3 48.1 31.5 73.6 43.2 72.1 33.8 35.9 34.9 52.3 19.7 28.2 21.3 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.2 - 58.8 104.6 97.7 - 105.1 96.3 153.8 - 78.9 90.2 58.4 - 29.7 60.1 239.7 - 252.2 188.2 -

DPO

4787.0 4768.9 1983.8 - 1246.5 1863.8 2068.1 - 1058.9 1176.7 1684.8 - 286.1 2013.7 2203.0 - 2335.8 3176.7 2445.3 - 1942.7 2069.8 3211.2 - 6150.2 2030.7 1380.0 - 1646.0 17118.5 2025.9 - 2506.2 1530.1 890.4 - 591.0 982.0 880.5 - 907.4 831.7 1982.3 - 1716.6 1962.1 1262.3 - 628.0 1270.1 5146.4 - 5510.2 2055.7 -

Operating Cycle

7.7 10.1 26.0 - 30.7 8.2 9.0 - 14.7 8.6 444.0 2061.0 42.6 - 28.2 62.2 19.3 - 3.9 1.6 - - 2.5 3.1 - - 9.1 6.7 - - 40.2 14.2 - - 16.8 49.5 82.8 130.8 139.4 30.1 147.1 141.6 201.9 31.5 152.5 133.4 130.5 33.8 65.7 95.0 292.1 19.7 280.4 209.5 -

Cash Conversion Cycle

-4779.3 -4758.7 -1957.8 - -1215.8 -1855.6 -2059.1 - -1044.2 -1168.1 -1240.8 2061.0 -243.5 -2013.7 -2174.8 62.2 -2316.5 -3176.7 -2441.4 1.6 -1942.7 -2069.8 -3208.7 3.1 -6150.2 -2030.7 -1371.0 6.7 -1646.0 -17118.5 -1985.7 14.2 -2506.2 -1530.1 -873.6 49.5 -508.3 -851.2 -741.1 30.1 -760.2 -690.1 -1780.4 31.5 -1564.1 -1828.8 -1131.8 33.8 -562.3 -1175.1 -4854.4 19.7 -5229.9 -1846.2 -

All numbers in USD currency